{"title": "PDF", "author": "PDF", "url": "https://www.medigraphic.com/pdfs/transfusional/mt-2009/mt091e.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 Enero - Abril, 2009 30www.medigraphic.com/65/114/116/237/99/117/108/111/32 /100/101/32 /114/101/118/105/115/105/243/110 /42/32/72/101/109/97/116/111/108/111/103/237/97/32/80/101/114/105/110/97/116/97/108/46/32/73/110/115/116/105/116/117/116/111/32/78/97/99/105/111/110/97/108/32/100/101/32/80/101/114/105/110/97/116/111/108/111/103/237/97/46/32/77/101/100/105/99/105/110/97/32/84/114/97/110/115/102/117/115/105/111/110/97/108/32/121/32/66/97/110/99/111/32/100/101/32/83/97/110/103/114/101/44/32/77/233/100/105/99/97/32/83/117/114/46Lo que no sabemos y lo que debemos saber acerca de las pruebas molecularesen el tamiz de infecciones transmitidaspor infecci\u00f3n en donadores de sangreen M\u00e9xico /72/233/99/116/111/114/32 /65/32 /66/97/112/116/105/115/116/97/45/71/111/110/122/225/108/101/122/42Asociaci\u00f3n Mexicana deMedicinaTransfusional, A.C. A M M T Vol. 2, N\u00fam. 1, Ene.-Abr. 2009 pp 30-40 Abstract /84/104/101/32/97/108/103/111/114/105/116/104/109/115/32/116/111/32/115/99/114/101/101/110/105/110/103/32/116/104/101/32/98/108/111/111/100/32/100/111/110/111/114/115/32/97/114/101/32/98/97/115/101/100 /112/114/105/109/97/114/105/108/121/32/111/110/32/115/101/114/111/108/111/103/105/99/32/116/101/115/116/115/32/98/121/32/105/109/109/117/110/111/101/110/122/121/109/101/32/116/101/99/104/110/105/113/117/101/115/44/109/97/105/110/108/121/32/69/76/73/83/65/44/32/99/111/109/112/114/105/115/101/32/111/102/32/116/104/101/32/109/111/115/116/32/114/97/116/105/111/110/97/108/32/115/99/104/101/109/101/32/97/110/100/119/105/116/104/32/97/32/98/101/116/116/101/114/32/114/101/115/117/108/116/32/99/111/115/116/45/101/102/102/101/99/116/105/118/101/110/101/115/115/32/114/101/97/115/111/110/32/119/104/121/32/117/115/105/110/103/105/115/32/116/104/101/32/109/101/116/104/111/100/111/108/111/103/121/32/109/111/114/101/46/32/73/110/32/111/114/100/101/114/32/116/111/32/98/101/32/97/98/108/101/32/116/111/32/105/110/99/108/117/100/101/32/97/110/101/119/32/116/101/115/116/32/105/110/32/116/104/101/32/115/99/114/101/101/110/105/110/103/32/111/102/32/98/108/111/111/100/32/100/111/110/111/114/115/44/32/119/101/32/109/117/115/116/32/99/111/109/45/112/108/101/116/101/32/99/111/109/112/117/108/115/111/114/105/108/121/44/32/99/101/114/116/97/105/110/32/101/112/105/100/101/109/105/111/108/111/103/105/115/116/115/32/97/110/100/32/116/101/99/104/110/105/45/99/105/97/110/115/32/99/114/105/116/101/114/105/97/32/116/111/32/98/101/32/97/98/108/101/32/116/111/32/111/98/116/97/105/110/32/97/32/102/97/118/111/114/97/98/108/101/32/105/109/112/97/99/116/32/111/110/109/111/100/105/102/105/99/97/116/105/111/110/32/111/102/32/110/97/116/117/114/97/108/32/104/105/115/116/111/114/121/32/111/102/32/116/104/101/32/100/105/115/101/97/115/101/44/32/116/111/32/111/98/116/97/105/110/116/104/101/32/102/101/97/115/105/98/105/108/105/116/121/32/97/110/100/32/118/105/97/98/105/108/105/116/121/32/111/102/32/105/110/116/101/114/118/101/110/116/105/111/110/32/101/118/97/108/117/97/116/101/100/32/98/121/97/110/32/105/110/116/101/103/114/97/116/105/118/101/32/115/116/117/100/121/32/111/102/32/102/97/118/111/114/97/98/108/101/32/99/111/115/116/45/101/102/102/105/99/105/101/110/99/121/46/32/84/104/101/32/97/100/45/100/105/116/105/111/110/97/108/32/116/101/115/116/115/32/40/112/50/52/44/32/97/110/116/105/45/72/66/99/41/32/111/114/32/109/111/108/101/99/117/108/97/114/32/116/101/99/104/110/105/113/117/101/115/104/97/118/101/32/103/101/110/101/114/97/116/101/100/32/97/110/32/97/100/100/101/100/32/118/97/108/117/101/32/105/110/32/116/104/105/115/32/112/114/111/99/101/115/115/32/111/102/32/115/99/114/101/101/110/45/105/110/103/32/119/105/116/104/32/118/97/114/105/97/98/108/101/32/114/101/115/117/108/116/115/46/32/83/117/102/102/105/99/105/101/110/116/32/105/110/102/111/114/109/97/116/105/111/110/32/116/104/97/116/32/100/111/101/115/110/111/116/32/101/120/105/115/116/32/105/116/32/100/101/109/111/110/115/116/114/97/116/101/115/32/105/110/32/115/99/105/101/110/116/105/102/105/99/32/116/101/99/104/110/105/99/97/108/32/116/101/114/109/115/44/32/108/105/107/101/111/116/104/101/114/32/105/110/116/101/114/118/101/110/116/105/111/110/115/32/105/110/32/104/101/97/108/116/104/44/32/116/104/101/32/97/100/118/97/110/116/97/103/101/115/32/111/102/32/116/104/101/32/109/111/45/108/101/99/117/108/97/114/32/115/116/117/100/105/101/115/32/98/121/32/97/32/117/110/105/118/101/114/115/97/108/32/115/116/114/97/116/101/103/121/32/105/110/32/116/101/115/116/105/110/103/32/98/108/111/111/100/100/111/110/111/114/115/46/32/84/104/101/32/107/110/111/119/108/101/100/103/101/32/111/102/32/116/104/101/32/112/114/111/99/101/115/115/32/116/111/32/115/116/117/100/121/32/98/108/111/111/100/100/111/110/111/114/115/44/32/97/110/100/32/116/104/101/32/112/101/114/115/105/115/116/101/110/116/32/114/101/112/111/114/116/115/32/111/102/32/116/104/101/32/104/105/103/104/115/101/114/111/112/114/101/118/97/108/101/110/99/101/44/32/105/110/100/105/99/97/116/101/32/116/111/32/101/118/105/100/101/110/116/32/102/97/117/108/116/115/32/105/110/32/116/97/99/116/105/99/97/108/108/121/105/109/112/111/114/116/97/110/116/32/112/111/105/110/116/115/32/111/102/32/101/100/117/99/97/116/105/111/110/32/102/111/114/32/116/104/101/32/104/101/97/108/116/104/44/32/112/114/111/109/111/116/105/111/110/111/102/32/98/108/111/111/100/32/100/111/110/97/116/105/111/110/32/97/110/100/32/109/101/100/105/99/97/108/32/101/118/97/108/117/97/116/105/111/110/32/105/110/32/116/104/101/32/115/101/108/101/99/45Resumen /76/111/115/32/97/108/103/111/114/105/116/109/111/115/32/112/97/114/97/32/101/108/32/116/97/109/105/122/32/100/101/32/108/111/115/32/100/111/110/97/100/111/114/101/115/32/100/101/32/115/97/110/45/103/114/101/32/115/101/32/98/97/115/97/110/32/112/114/105/109/97/114/105/97/109/101/110/116/101/32/101/110/32/101/115/116/117/100/105/111/115/32/115/101/114/111/108/243/103/105/99/111/115/109/101/100/105/97/110/116/101/32/116/233/99/110/105/99/97/115/32/105/110/109/117/110/111/101/110/122/105/109/225/116/105/99/97/115/44/32/112/114/105/110/99/105/112/97/108/109/101/110/116/101/69/76/73/83/65/44/32/102/111/114/109/97/110/32/112/97/114/116/101/32/100/101/108/32/101/115/113/117/101/109/97/32/109/225/115/32/114/97/99/105/111/110/97/108/32/121/32/99/111/110/109/101/106/111/114/32/114/101/115/117/108/116/97/100/111/32/99/111/115/116/111/45/101/102/101/99/116/105/118/105/100/97/100/44/32/112/111/114/32/108/111/32/113/117/101/32/101/115/32/108/97/32/109/101/45/116/111/100/111/108/111/103/237/97/32/109/225/115/32/101/109/112/108/101/97/100/97/46/32/80/97/114/97/32/112/111/100/101/114/32/105/110/99/108/117/105/114/32/117/110/97/32/110/117/101/45/118/97/32/112/114/117/101/98/97/32/101/110/32/101/108/32/116/97/109/105/122/32/100/101/32/108/111/115/32/100/111/110/97/100/111/114/101/115/32/100/101/32/115/97/110/103/114/101/44/32/115/101/100/101/98/101/110/32/99/117/109/112/108/105/114/32/111/98/108/105/103/97/100/97/109/101/110/116/101/44/32/99/105/101/114/116/111/115/32/99/114/105/116/101/114/105/111/115/101/112/105/100/101/109/105/111/108/243/103/105/99/111/115/32/121/32/116/233/99/110/105/99/111/115/32/112/97/114/97/32/112/111/100/101/114/32/108/111/103/114/97/114/32/117/110/32/105/109/45/112/97/99/116/111/32/102/97/118/111/114/97/98/108/101/32/101/110/32/108/97/32/109/111/100/105/102/105/99/97/99/105/243/110/32 /100/101/32/108/97/32/104/105/115/116/111/114/105/97/32/110/97/116/117/45 1, pp 30-40 \u0081 Enero - Abril, 2009Baptista-Gonz\u00e1lez HA. Pruebas moleculares en el tamiz de infecciones transmitidas por donadores Variables que intervienen en el perfil de una prueba de escrutinio. Criterios epidemiol\u00f3gicos: \u0081 Prevalencia de la enfermedad (si la frecuencia de detecci\u00f3n es demasiado baja, el costo por caso podr\u00eda ser elevado, consecuentemente con una escasa reducci\u00f3n de la morbilidad y mortalidad) \u0081 Tasa de incidencia de la enfermedad\u0081 Duraci\u00f3n promedio de la fase precl\u00ednica\u0081 Tamiz previo en los donadores (donador voluntario o reposici\u00f3n, de primera vez o repetici\u00f3n, con selecci\u00f3n m\u00e9dica o con serol\u00f3gica dirigida, etc.) Criterios t\u00e9cnicos: \u0081 Evaluaci\u00f3n de desempe\u00f1o de la prueba (pruebas diagn\u00f3sticas, esperando obtener la m\u00e1xima sensibilidad e ideal, pero no obligadamente, tambi\u00e9n una m\u00e1xima especificidad, que genere una tasa baja de falsos positivos, pues los valores predictivosdependen de la prevalencia de la enfermedad) \u0081 Validez interna y externa comprobada\u0081 Puntos claros de corte\u0081 Disponibilidad opcional de prueba suplementaria\u0081 Disponibilidad de prueba confirmatoria\u0081 Estrategia de tamiz en pruebas en paralelo o en serie Criterio de integraci\u00f3n: \u0081 Documentaci\u00f3n sobre en el tamiz de infecciones transmitidas por donadores de sangre Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 seroprevalencia reportada en donadoresde sangre 1990-2005.Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 Enero - Abril, 2009Baptista-Gonz\u00e1lez HA. Pruebas moleculares en el tamiz de infecciones transmitidas por donadores en el tamiz de infecciones transmitidas por donadores de sangre Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 1, pp 30-40 \u0081 Enero - Abril, 2009Baptista-Gonz\u00e1lez HA. Pruebas moleculares en el tamiz de infecciones transmitidas por donadores de sangre 35www.medigraphic.com/112/114/111/112/117/101/115/116/97/115/32/112/97/114/97/32/114/101/101/109/112/108/97/122/97/114/108/97/32/99/111/110/32/117/110/97/32/112/114/101/45 en el tamiz de infecciones transmitidas por donadores de sangre Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 1, pp 30-40 \u0081 Enero - Abril, 2009Baptista-Gonz\u00e1lez HA. Pruebas moleculares en el tamiz de infecciones transmitidas por donadores en el tamiz de infecciones transmitidas por donadores de sangre Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 Enero - Abril, 2009 38www.medigraphic.comESTE Cuadro III. Estrategia molecular en el tamiz de donadores. Variables relacionadas. \u0081 Marcador \u00fanico o combinado con dos o tres m\u00e1s\u0081 Pruebas en serie: s\u00f3lo incluir aqu\u00e9llos con estudio serol\u00f3gico negativo. Con o sin pruebas suplementarias previas\u0081 Pruebas en paralelo: Correr simult\u00e1neamente molecular y serol\u00f3gico\u0081 Ajustes a la endemicidad local del marcador\u0081 Evaluaci\u00f3n de inmunoensayos de alta sensibilidad\u0081 T\u00e9cnicos 1. Metodolog\u00eda2. T\u00e9cnica de concentraci\u00f3n viral3. Muestras sencillas4. Tama\u00f1o del minipool, igual o distinto para cada marcador5. Sensibilidad anal\u00edtica6. Tipo de calibradorRev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 Enero - Abril, 2009Baptista-Gonz\u00e1lez HA. Pruebas moleculares en el tamiz de infecciones transmitidas por donadores en el tamiz de infecciones transmitidas por donadores de sangre Rev Mex Med Tran, Vol. 2, N\u00fam. 1, pp 30-40 \u0081 Montes Urales N\u00fam. 800,Lomas Virreyes, Delegaci\u00f3n "}